Systemic health implications of dental prescribing in general practices.

Overview

This review examines the systemic health implications of medications frequently prescribed in general dental practice, specifically analgesics, antibiotics, and antiseptic mouthwashes. The analysis addresses how short-term adjunctive medications used to manage pain, infection, and postoperative recovery can produce effects on cardiovascular, renal, hepatic, metabolic systems and alter the microbiome beyond the oral cavity. The review synthesizes evidence on mechanisms of action, clinical implications, and stewardship opportunities for three major medication classes commonly administered by general dental practitioners.

Methods and approach

The review summarizes existing evidence regarding systemic health effects of nonsteroidal anti-inflammatory drugs, acetaminophen, opioids, gabapentinoids, antibiotics, and antiseptic mouthwashes in the context of dental prescribing. For each medication class, the authors discuss pharmacological mechanisms, susceptible patient populations, documented adverse effects, resistance patterns, and microbiome disruption. The analysis incorporates considerations of antimicrobial stewardship, opioid substitution safety, penicillin allergy mislabeling, and vascular implications of antiseptic agents.

Key Findings

NSAIDs represent first-line analgesic therapy for dental pain but can impair renal function, elevate blood pressure, and compromise gastrointestinal integrity in vulnerable populations even with brief courses. Acetaminophen is suitable for mild to moderate dental pain but poses hepatotoxicity risks at cumulative doses. Opioids, historically prescribed after tooth extractions and surgical procedures, demonstrate no analgesic superiority over non-opioid alternatives while contributing to community-level opioid misuse; gabapentinoids emerge as lower-risk alternatives but require cautious application. Antibiotic prescribing for non-indicated conditions elevates antimicrobial resistance risk, produces gut microbiome dysbiosis, and increases Clostridioides difficile infection incidence. Penicillin allergy mislabeling drives substitution with higher-risk agents such as clindamycin. Chlorhexidine mouthwashes effectively reduce oral microbial burden but suppress nitrate-reducing oral bacteria and may disrupt nitric oxide-mediated vascular function.

Implications

General dental practitioners occupy a critical position in medication stewardship and systemic health risk mitigation. Integration of systemic health awareness into prescribing decisions requires consideration of individual patient profiles, comorbidities, and concomitant medications when selecting analgesics and antibiotics. The evidence against routine opioid prescription for dental procedures, coupled with documentation of non-opioid efficacy, supports practice pattern modification toward opioid-sparing analgesia. Practitioners should implement measures to clarify penicillin allergy history and reduce inappropriate substitution with broader-spectrum agents. Antimicrobial stewardship in dental settings necessitates adherence to evidence-based prescribing guidelines that restrict antibiotics to clinically indicated infections rather than prophylactic administration. The systemic consequences of antiseptic mouthwash use, particularly effects on oral nitrate metabolism and vascular endothelial function, warrant selective rather than routine application and patient education regarding appropriate use duration.